XORTX Therapeutics Inc. (XRTX.V)
CAD 1.62
(-7.43%)
CAD 1.62
(-7.43%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.44 CAD | 69.49% |
| 2022 | -4.72 CAD | -296.64% |
| 2021 | -1.19 CAD | 31.21% |
| 2020 | -1.73 CAD | -63.21% |
| 2019 | -1.06 CAD | 83.57% |
| 2018 | -6.45 CAD | -187.95% |
| 2017 | -2.24 CAD | -9.27% |
| 2016 | -2.05 CAD | 0.0% |
| 2014 | -0.49 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -1.24 USD | -201.64% |
| 2024 Q2 | 0.07 USD | 105.65% |
| 2023 Q2 | -0.85 USD | 10.53% |
| 2023 FY | - CAD | 68.86% |
| 2023 Q3 | -0.67 USD | 21.18% |
| 2023 Q4 | 1.22 USD | 282.09% |
| 2023 Q1 | -0.95 USD | 47.22% |
| 2022 Q2 | -1.10 CAD | 53.78% |
| 2022 Q1 | -2.38 CAD | -137.78% |
| 2022 Q4 | -1.80 CAD | -66.67% |
| 2022 Q3 | -1.08 CAD | 1.82% |
| 2022 FY | - CAD | -296.64% |
| 2021 FY | - CAD | 31.21% |
| 2021 Q4 | 6.30 CAD | 178.46% |
| 2021 Q2 | -0.21 CAD | 91.21% |
| 2021 Q1 | -2.39 CAD | -305.08% |
| 2021 Q3 | -8.03 CAD | -3723.81% |
| 2020 Q4 | -0.59 CAD | -7.27% |
| 2020 Q2 | -0.49 CAD | -868.38% |
| 2020 Q1 | -0.05 CAD | 84.19% |
| 2020 FY | - CAD | -63.21% |
| 2020 Q3 | -0.55 CAD | -12.24% |
| 2019 Q1 | -0.23 CAD | 8.0% |
| 2019 FY | - CAD | 83.57% |
| 2019 Q2 | -0.26 CAD | -13.04% |
| 2019 Q4 | -0.32 CAD | -45.45% |
| 2019 Q3 | -0.22 CAD | 15.38% |
| 2018 Q1 | -5.57 CAD | -364.17% |
| 2018 Q4 | -0.25 CAD | 51.92% |
| 2018 Q2 | -0.46 CAD | 91.74% |
| 2018 Q3 | -0.52 CAD | -13.04% |
| 2018 FY | - CAD | -187.95% |
| 2017 Q1 | -0.31 CAD | 20.51% |
| 2017 FY | - CAD | -9.27% |
| 2017 Q4 | -1.20 CAD | -192.68% |
| 2017 Q3 | -0.41 CAD | -64.0% |
| 2017 Q2 | -0.25 CAD | 19.35% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q4 | -0.39 CAD | 0.0% |
| 2016 Q3 | -0.39 CAD | -18.18% |
| 2016 Q2 | -0.33 CAD | -375.0% |
| 2016 Q1 | 0.12 CAD | 111.11% |
| 2015 Q1 | -0.22 CAD | -183.14% |
| 2015 Q2 | -0.68 CAD | -209.09% |
| 2015 Q4 | -1.08 CAD | -111.76% |
| 2015 Q3 | -0.51 CAD | 25.0% |
| 2014 Q3 | -0.08 CAD | -3.58% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q2 | -0.08 CAD | 0.0% |
| 2014 Q4 | -0.08 CAD | 4.19% |
| Name | Eps | Eps Difference |
|---|---|---|
| Arch Biopartners Inc. | -0.05 CAD | -2601.689% |
| Covalon Technologies Ltd. | -0.18 CAD | -700.0% |
| Hemostemix Inc. | -0.03 CAD | -4652.475% |
| Universal Ibogaine Inc. | -0.06 CAD | -2448.673% |
| Kane Biotech Inc. | -0.04 CAD | -3911.142% |
| MedMira Inc. | -0.00 CAD | -37794.737% |
| Marvel Biosciences Corp. | -0.06 CAD | -2391.349% |
| NervGen Pharma Corp. | -0.38 CAD | -278.947% |